Skip to content

Clinical trials

Completed Cholangiocarcinoma trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cholangiocarcinoma Status: Completed Country / region: Taiwan Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20142
20152
20162
20173
20193
20201
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie2
Merck Sharp & Dohme LLC2
ASLAN Pharmaceuticals1
Chang Gung Memorial Hospital1
EMD Serono Research & Development Institute, Inc.1
Elevar Therapeutics1
Incyte Corporation1
Janssen Research & Development, LLC1
Kaohsiung Medical University Chung-Ho Memorial Hospital1
National Chung Hsing University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cholangiocarcinoma15
Stomach Neoplasms5
Carcinoma, Hepatocellular4
Biliary Tract Neoplasms3
Carcinoma, Non-Small-Cell Lung3
Gallbladder Neoplasms3
Neoplasms3
Ovarian Neoplasms3
Triple Negative Breast Neoplasms3
Acrocephalosyndactylia2

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.